Back

Serial high-sensitivity troponin-I and long-term risk of myocardial infarction and coronary revascularization in subjects with suspected acute coronary syndrome

25 August 2023 (13:15 - 13:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes (1) Biomarkers ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Checkpoint nano-degrader to transiently promote efferocytosis in acute myocardial infarction
Mr J. Gao (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
GDF-15 is associated with worse ischemic and bleeding outcomes in the acute phase and during follow-up in patients with acute coronary syndrome: insights from the TRACER trial
Doctor C. Wassberg (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
The specificity of cardiac troponin elevations for myocardial infarction declines with age
Doctor R. Hasselbalch (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Growth differentiation factor-15 is associated with myocardial infarction and death at 30 and 90 days in ED patients with suspected acute coronary syndrome
Doctor B. Allen (Gainesville, US)
Abstract Slides Video
Presentation thumbnail
Effect of symptoms recognition in patients with recurrent acute myocardial infarction: from KRAMI-RCC
Doctor K. Kim (Jinju, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes (1)

The Event

Event poster

ESC Congress 2023

25 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
High-sensitivity troponin-i and risk of heart failure in individuals with suspected acute coronary syndrome
thumbnail
Congress Presentation
High-Sensitivity Troponin-T and heart failure risk in individuals with suspected acute coronary syndrome
thumbnail
Congress Presentation
Impact of switching high-sensitivity cardiac troponin assays on risk stratification in suspected acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources